• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Marked improvement of elderly postprandial hypotension by dipeptidyl peptidase IV inhibitor.

作者信息

Yonenaga Akihiko, Ota Hidetaka, Honda Masayuki, Koshiyama Daisuke, Yagi Takashi, Hanaoka Yoko, Yamamoto Hiroshi, Yamaguchi Yasuhiro, Iijima Katsuya, Akishita Masahiro, Ouchi Yasuyoshi

出版信息

Geriatr Gerontol Int. 2013 Jan;13(1):227-9. doi: 10.1111/j.1447-0594.2012.00903.x.

DOI:10.1111/j.1447-0594.2012.00903.x
PMID:23286563
Abstract
摘要

相似文献

1
Marked improvement of elderly postprandial hypotension by dipeptidyl peptidase IV inhibitor.二肽基肽酶IV抑制剂显著改善老年餐后低血压。
Geriatr Gerontol Int. 2013 Jan;13(1):227-9. doi: 10.1111/j.1447-0594.2012.00903.x.
2
[Vildagliptin].维格列汀
Nihon Rinsho. 2011 May;69(5):865-70.
3
The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes.维格列汀治疗对2型糖尿病患者致动脉粥样硬化餐后残余颗粒及低密度脂蛋白颗粒大小的影响。
Diabet Med. 2013 Jun;30(6):756-7. doi: 10.1111/dme.12094.
4
Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.胰岛增强剂维格列汀：与二甲双胍联合治疗2型糖尿病患者的有力搭档。
Diabetes Obes Metab. 2009 May;11 Suppl 2:1-2. doi: 10.1111/j.1463-1326.2008.01032.x.
5
A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors.二肽基肽酶-4抑制剂诱发大疱性类天疱疮一例报告
JAMA Dermatol. 2013 Feb;149(2):243-5. doi: 10.1001/jamadermatol.2013.1073.
6
Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats.维格列汀可抑制链脲佐菌素诱导的糖尿病大鼠的氧化应激和血管损伤。
Int J Cardiol. 2012 Jun 28;158(1):171-3. doi: 10.1016/j.ijcard.2012.04.087. Epub 2012 May 6.
7
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.二肽基肽酶-IV抑制剂维格列汀对糖耐量受损受试者肠促胰岛素激素、胰岛功能及餐后血糖的影响。
Diabetes Care. 2008 Jan;31(1):30-5. doi: 10.2337/dc07-1616. Epub 2007 Oct 18.
8
Vildagliptin in clinical practice: a review of literature.维格列汀的临床应用：文献复习。
Expert Opin Pharmacother. 2009 Nov;10(16):2745-57. doi: 10.1517/14656560903302265.
9
Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patient.在减少血糖波动与提高治疗依从性之间：维格列汀对一位老年糖尿病患者益处的实例
Aging Clin Exp Res. 2015 Feb;27(1):85-7. doi: 10.1007/s40520-014-0235-x. Epub 2014 Apr 30.
10
Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes.二肽基肽酶4抑制与维格列汀治疗2型糖尿病
Int J Clin Pract Suppl. 2007 Aug(154):38-48. doi: 10.1111/j.1742-1241.2007.01439.x.

引用本文的文献

1
Potential for Gut Peptide-Based Therapy in Postprandial Hypotension.基于肠道肽的餐后低血压治疗潜力。
Nutrients. 2021 Aug 17;13(8):2826. doi: 10.3390/nu13082826.
2
Acarbose for Postprandial Hypotension With Glucose Metabolism Disorders: A Systematic Review and Meta-Analysis.阿卡波糖治疗伴有葡萄糖代谢紊乱的餐后低血压：一项系统评价和荟萃分析。
Front Cardiovasc Med. 2021 May 20;8:663635. doi: 10.3389/fcvm.2021.663635. eCollection 2021.
3
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial.
利拉鲁肽与磺酰脲类格列美脲对超重 2 型糖尿病患者全身血液动力学的影响：8 周随机、对照、双盲临床试验的二次分析。
Diabetes Obes Metab. 2020 Oct;22(10):1847-1856. doi: 10.1111/dom.14107. Epub 2020 Jun 22.
4
Postprandial and Orthostatic Hypotension Treated by Sitagliptin in a Patient with Dementia with Lewy Bodies.西他列汀治疗路易体痴呆患者的餐后和体位性低血压
Am J Case Rep. 2016 Nov 25;17:887-893. doi: 10.12659/AJCR.900620.
5
Current pharmacological management of hypotensive syndromes in the elderly.老年人低血压综合征的当前药物治疗
Drugs Aging. 2015 May;32(5):337-48. doi: 10.1007/s40266-015-0263-z.